|
US8609816B2
(en)
*
|
2005-12-08 |
2013-12-17 |
Medarex, L.L.C. |
Human monoclonal antibodies to O8E
|
|
JP2010519310A
(ja)
*
|
2007-02-21 |
2010-06-03 |
メダレックス インコーポレイテッド |
単一のアミノ酸を有する化学リンカーおよびその複合体
|
|
EP2185188B1
(en)
|
2007-08-22 |
2014-08-06 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
|
|
HRP20150074T1
(hr)
|
2007-10-01 |
2015-03-13 |
Bristol-Myers Squibb Company |
Humana antitijela koja se vežu za mezotelin i njihove uporabe
|
|
AR069747A1
(es)
*
|
2007-11-30 |
2010-02-17 |
Medarex Inc |
Conjugado anticuerpo monoclonal anti-b7h4- farmaco y metodos de utilizacion
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
HUE035798T2
(en)
|
2008-11-03 |
2018-05-28 |
Syntarga Bv |
CC-1065 analogues and conjugates
|
|
JP5816558B2
(ja)
|
2009-03-05 |
2015-11-18 |
メダレックス・リミテッド・ライアビリティ・カンパニーＭｅｄａｒｅｘ， Ｌ．Ｌ．Ｃ． |
Ｃａｄｍ１に特異的な完全ヒト抗体
|
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
|
EP2462238B1
(en)
*
|
2009-08-07 |
2013-07-17 |
Ohmx Corporation |
Enzyme triggered redox altering chemical elimination (e-trace) immunoassay
|
|
US9250234B2
(en)
|
2011-01-19 |
2016-02-02 |
Ohmx Corporation |
Enzyme triggered redox altering chemical elimination (E-TRACE) immunoassay
|
|
PT2528625E
(pt)
*
|
2010-04-15 |
2013-10-17 |
Spirogen Sarl |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
NO3056203T3
(cg-RX-API-DMAC10.html)
|
2010-04-21 |
2018-05-12 |
|
|
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
|
US8501930B2
(en)
*
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
US8852599B2
(en)
|
2011-05-26 |
2014-10-07 |
Bristol-Myers Squibb Company |
Immunoconjugates, compositions for making them, and methods of making and use
|
|
WO2013059293A1
(en)
|
2011-10-17 |
2013-04-25 |
Ohmx Corporation |
Single, direct detection of hemoglobin a1c percentage using enzyme triggered redox altering chemical elimination (e-trace) immunoassay
|
|
CA2854459A1
(en)
|
2011-11-04 |
2013-05-10 |
Ohmx Corporation |
Novel chemistry used in biosensors
|
|
CA2860739A1
(en)
|
2012-01-09 |
2013-07-18 |
Ohmx Corporation |
Enzyme cascade methods for e-trace assay signal amplification
|
|
PL2814829T3
(pl)
|
2012-02-13 |
2017-06-30 |
Bristol-Myers Squibb Company |
Związki enediyny, ich koniugaty oraz zastosowanie i sposoby ich wytwarzania
|
|
AU2013270683A1
(en)
|
2012-06-08 |
2014-12-11 |
Biogen Ma Inc. |
Chimeric clotting factors
|
|
AU2013270682A1
(en)
|
2012-06-08 |
2014-12-11 |
Biogen Ma Inc. |
Procoagulant compounds
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
CA2880104A1
(en)
|
2012-07-27 |
2014-01-30 |
Ohmx Corporation |
Electric measurement of monolayers following pro-cleave detection of presence and activity of enzymes and other target analytes
|
|
EP2877592B1
(en)
|
2012-07-27 |
2016-09-21 |
Ohmx Corporation |
Electronic measurements of monolayers following homogeneous reactions of their components
|
|
KR20210132742A
(ko)
|
2012-12-21 |
2021-11-04 |
알트루바이오 인코퍼레이티드 |
친수성 자기-희생 링커 및 그것의 포합체
|
|
DK2956173T3
(en)
|
2013-02-14 |
2017-07-17 |
Bristol Myers Squibb Co |
TUBULYSIS RELATIONSHIPS, METHODS OF PRODUCING AND USING THEREOF
|
|
HK1220626A1
(zh)
|
2013-03-15 |
2017-05-12 |
The Centre For Drug Research And Development |
具细胞毒性和抗有丝分裂的化合物以及其使用方法
|
|
DK2991683T3
(da)
|
2013-05-02 |
2019-11-04 |
Glykos Finland Oy |
Konjugater af et glykoprotein eller en glykan med en toksisk ladning
|
|
BR112016002829A2
(pt)
|
2013-08-12 |
2017-09-19 |
Genentech Inc |
Composto e processo para preparar o composto de conjugado anticorpo-¿droga, composição farmacêutica, método de tratamento do câncer, kit para o tratamento do câncer, intermediário ligante¿-droga, porção e composto de porção droga de dímero cbi
|
|
KR20250051130A
(ko)
|
2013-09-25 |
2025-04-16 |
싸이톰스 테라퓨틱스, 인크. |
매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법
|
|
JP6980384B2
(ja)
*
|
2013-12-16 |
2021-12-15 |
ジェネンテック， インコーポレイテッド |
１−（クロロメチル）−２，３−ジヒドロ−１ｈ−ベンゾ［ｅ］インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法
|
|
KR102384740B1
(ko)
|
2013-12-27 |
2022-04-07 |
자임워크스 인코포레이티드 |
약물 접합체를 위한 설폰아마이드-함유 연결 시스템
|
|
TR201810856T4
(tr)
|
2014-01-10 |
2018-08-27 |
Synthon Biopharmaceuticals Bv |
CYS'le bağlı antikor-ilaç konjugatlarını saflaştırmak için usul.
|
|
SG11201607818WA
(en)
|
2014-03-20 |
2016-10-28 |
Bristol Myers Squibb Co |
Stabilized fibronectin based scaffold molecules
|
|
PL3151921T3
(pl)
|
2014-06-06 |
2020-02-28 |
Bristol-Myers Squibb Company |
Przeciwciała przeciwko receptorowi indukowanego glukokortykoidami czynnika martwicy nowotworu (gitr) i ich zastosowania
|
|
KR20170020868A
(ko)
|
2014-06-20 |
2017-02-24 |
바이오얼라이언스 씨.브이. |
항-폴레이트 수용체 알파 (fra) 항체-약물 컨쥬게이트 및 그것의 사용 방법
|
|
US10973920B2
(en)
|
2014-06-30 |
2021-04-13 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
US20160041118A1
(en)
|
2014-08-11 |
2016-02-11 |
Ohmx Corporation |
Enzyme triggered redox altering chemical elimination (e-trace) assay with multiplexing capabilities
|
|
HRP20241124T1
(hr)
*
|
2014-09-11 |
2024-11-22 |
Seagen Inc. |
Ciljana isporuka lijekovitih tvari koje sadrže tercijarni amin
|
|
ES2905569T3
(es)
|
2014-09-17 |
2022-04-11 |
Zymeworks Inc |
Compuestos citotóxicos y antimitóticos y métodos para utilizarlos
|
|
CN104356048B
(zh)
*
|
2014-11-02 |
2016-08-24 |
浙江医药高等专科学校 |
环己烷羧酸酰胺类衍生物、其制备方法和用途
|
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
|
ES2826566T3
(es)
|
2014-11-21 |
2021-05-18 |
Bristol Myers Squibb Co |
Anticuerpos que comprenden regiones constantes pesadas modificadas
|
|
JP6805142B2
(ja)
|
2014-11-21 |
2020-12-23 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｃｄ７３に対する抗体およびその使用
|
|
WO2016086036A2
(en)
|
2014-11-25 |
2016-06-02 |
Bristol-Myers Squibb Company |
Methods and compositions for 18f-radiolabeling of biologics
|
|
JP6622814B2
(ja)
|
2014-11-25 |
2019-12-18 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
イメージングのための新規ｐｄ−ｌ１結合ポリペプチド
|
|
WO2016100834A2
(en)
|
2014-12-19 |
2016-06-23 |
Ohmx Corporation |
Competitive enzymatic assays
|
|
EP3233912B1
(en)
|
2014-12-19 |
2021-05-19 |
Regenesance B.V. |
Antibodies that bind human c6 and uses thereof
|
|
CN107231804B
(zh)
|
2015-01-14 |
2019-11-26 |
百时美施贵宝公司 |
亚杂芳基桥连苯并二氮杂*二聚体、其缀合物及制备和使用方法
|
|
IL300408B2
(en)
|
2015-01-20 |
2025-11-01 |
Cytomx Therapeutics Inc |
Matrix metalloprotease-cleavable and serine protease cleavable substrates and methods of use thereof
|
|
ES2736106T3
(es)
|
2015-03-10 |
2019-12-26 |
Bristol Myers Squibb Co |
Anticuerpos que se pueden conjugar mediante la transglutaminasa y conjugados producidos a partir de ellos
|
|
AU2016271111B2
(en)
|
2015-05-29 |
2022-04-28 |
Bristol-Myers Squibb Company |
Antibodies against OX40 and uses thereof
|
|
WO2017048728A1
(en)
*
|
2015-09-14 |
2017-03-23 |
Rutgers, The State University Of New Jersey |
Targeted conjugates
|
|
EP3353198B1
(en)
|
2015-09-23 |
2020-06-17 |
Bristol-Myers Squibb Company |
Glypican-3binding fibronectin based scafflold molecules
|
|
TWI660741B
(zh)
|
2015-11-03 |
2019-06-01 |
財團法人工業技術研究院 |
抗體藥物複合物及其製造方法
|
|
MX2018006072A
(es)
|
2015-11-19 |
2018-08-01 |
Squibb Bristol Myers Co |
Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos.
|
|
GB2545169B
(en)
*
|
2015-12-01 |
2019-10-09 |
Ellipses Pharma Ltd |
Taxane Prodrug Comprising A Membrane Type Matrix Metalloproteinase Cleavage Site
|
|
US11229708B2
(en)
|
2015-12-04 |
2022-01-25 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
EP3394096A1
(en)
|
2015-12-21 |
2018-10-31 |
Bristol-Myers Squibb Company |
Variant antibodies for site-specific conjugation
|
|
WO2017120534A1
(en)
|
2016-01-08 |
2017-07-13 |
Bioalliance C.V. |
Tetravalent anti-psgl-1 antibodies and uses thereof
|
|
AU2017228470A1
(en)
|
2016-03-04 |
2018-08-30 |
Bristol-Myers Squibb Company |
Combination therapy with anti-CD73 antibodies
|
|
CN109069633A
(zh)
|
2016-04-15 |
2018-12-21 |
宏观基因有限公司 |
新颖的b7-h3-结合分子、其抗体药物缀合物及其使用方法
|
|
WO2017210335A1
(en)
|
2016-06-01 |
2017-12-07 |
Bristol-Myers Squibb Company |
Imaging methods using 18f-radiolabeled biologics
|
|
CN109562195A
(zh)
|
2016-06-01 |
2019-04-02 |
百时美施贵宝公司 |
用pd-l1结合多肽进行pet成像
|
|
US20190248893A1
(en)
|
2016-07-14 |
2019-08-15 |
Bristol-Myers Squibb Company |
Antibodies against tim3 and uses thereof
|
|
WO2018035391A1
(en)
|
2016-08-19 |
2018-02-22 |
Bristol-Myers Squibb Company |
Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and methods of making and use
|
|
US20190218294A1
(en)
|
2016-09-09 |
2019-07-18 |
Bristol-Myers Squibb Company |
Use of an anti-pd-1 antibody in combination with an anti-mesothelin antibody in cancer treatment
|
|
WO2018064094A1
(en)
|
2016-09-28 |
2018-04-05 |
Bristol-Myers Squibb Company |
Enantioselective synthesis of pyrroloindole compounds
|
|
IL310865A
(en)
*
|
2016-10-17 |
2024-04-01 |
Pfizer |
Antibodies against EDB and antibody-drug conjugates
|
|
US10398783B2
(en)
|
2016-10-20 |
2019-09-03 |
Bristol-Myers Squibb Company |
Antiproliferative compounds and conjugates made therefrom
|
|
JP7136790B2
(ja)
|
2017-02-17 |
2022-09-13 |
ブリストル－マイヤーズ スクイブ カンパニー |
アルファ－シヌクレインに対する抗体およびその使用
|
|
US11339218B2
(en)
|
2017-05-10 |
2022-05-24 |
Zhejiang Shimai Pharmaceutical Co., Ltd. |
Human monoclonal antibodies against LAG3 and uses thereof
|
|
EP3630189A4
(en)
|
2017-05-24 |
2021-06-23 |
The Board of Regents of The University of Texas System |
LINKER FOR ANTIBODY MEDICINAL CONJUGATES
|
|
MX2019013132A
(es)
|
2017-05-25 |
2020-01-27 |
Bristol Myers Squibb Co |
Anticuerpos que comprenden regiones constantes pesadas modificadas.
|
|
EP4092013A1
(en)
|
2017-06-20 |
2022-11-23 |
Imbria Pharmaceuticals, Inc. |
Compositions and methods for increasing efficiency of cardiac metabolism
|
|
US10487084B2
(en)
|
2017-08-16 |
2019-11-26 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
|
|
US10457681B2
(en)
|
2017-08-16 |
2019-10-29 |
Bristol_Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor
|
|
US10508115B2
(en)
|
2017-08-16 |
2019-12-17 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
|
|
US10494370B2
(en)
|
2017-08-16 |
2019-12-03 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
|
|
US10472361B2
(en)
|
2017-08-16 |
2019-11-12 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor
|
|
WO2019075090A1
(en)
|
2017-10-10 |
2019-04-18 |
Tilos Therapeutics, Inc. |
ANTI-LAP ANTIBODIES AND USES THEREOF
|
|
JP7358361B2
(ja)
|
2018-01-12 |
2023-10-10 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｔｉｍ３に対する抗体およびその使用
|
|
JP7351845B2
(ja)
|
2018-03-23 |
2023-09-27 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｍｉｃａおよび／またはｍｉｃｂに対する抗体ならびにそれらの使用
|
|
CR20250022A
(es)
|
2018-04-02 |
2025-02-25 |
Bristol Myers Squibb Co |
Anticuerpos anti-trem-1, ácidos nucleicos y vectores de los mismos (divisional 2020-0450)
|
|
WO2019209811A1
(en)
|
2018-04-24 |
2019-10-31 |
Bristol-Myers Squibb Company |
Macrocyclic toll-like receptor 7 (tlr7) agonists
|
|
WO2019246445A1
(en)
|
2018-06-20 |
2019-12-26 |
The Research Foundation For The State University Of New York |
Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same
|
|
MX2020013923A
(es)
|
2018-06-29 |
2021-03-29 |
Apitbio Inc |
Anticuerpos anti molécula de adhesión celular l1 (l1cam) y usos de estos.
|
|
US11554120B2
(en)
|
2018-08-03 |
2023-01-17 |
Bristol-Myers Squibb Company |
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
|
|
EA202190755A1
(ru)
|
2018-09-12 |
2021-06-11 |
Технише Универзитет Мюнхен |
Агенты для терапии и диагностики рака
|
|
CN119661653A
(zh)
*
|
2018-09-12 |
2025-03-21 |
慕尼黑工业大学 |
具有降低的物种选择性的cxcr4靶向诊断和治疗剂
|
|
EP3863722A2
(en)
|
2018-10-10 |
2021-08-18 |
Tilos Theapeutics, Inc. |
Anti-lap antibody variants and uses thereof
|
|
US12318382B2
(en)
|
2018-10-17 |
2025-06-03 |
Imbria Pharmaceuticals, Inc. |
Methods of treating rheumatic diseases using trimetazidine-based compounds
|
|
HUE059919T2
(hu)
|
2018-11-09 |
2023-01-28 |
Byondis Bv |
Duokarmicintartalmú antitest-hatóanyag konjugátum szûrhetõ készítményei és ezekkel kapcsolatos eljárások
|
|
JP2022513653A
(ja)
|
2018-11-28 |
2022-02-09 |
ブリストル－マイヤーズ スクイブ カンパニー |
修飾された重鎖定常領域を含む抗体
|
|
DK3886914T3
(da)
|
2018-11-30 |
2023-07-03 |
Bristol Myers Squibb Co |
Antistof omfattende en glutaminholdig letkæde-c-terminal forlængelse, konjugater deraf og fremgangsmåder samt anvendelser
|
|
US12139551B2
(en)
|
2018-12-03 |
2024-11-12 |
Bristol-Myers Squibb Company |
Anti-IDO antibody and uses thereof
|
|
TWI744730B
(zh)
|
2018-12-04 |
2021-11-01 |
田德揚 |
用於遞送抗癌劑之立體複合物
|
|
JP2022512124A
(ja)
|
2018-12-06 |
2022-02-02 |
シートムエックス セラピューティクス，インコーポレイテッド |
マトリックスメタロプロテアーゼ切断可能なおよびセリンまたはシステインプロテアーゼ切断可能な基質ならびにそれらの使用方法
|
|
WO2020123425A2
(en)
|
2018-12-12 |
2020-06-18 |
Bristol-Myers Squibb Company |
Antibodies modified for transglutaminase conjugation, conjugates thereof, and methods and uses
|
|
CN109762067B
(zh)
|
2019-01-17 |
2020-02-28 |
北京天广实生物技术股份有限公司 |
结合人Claudin 18.2的抗体及其用途
|
|
CN118894938A
(zh)
|
2019-01-22 |
2024-11-05 |
百时美施贵宝公司 |
抗IL-7Rα亚基的抗体及其用途
|
|
US12702719B2
(en)
|
2019-03-06 |
2026-08-11 |
Northwestern University |
Hairpin-like oligonucleotide-conjugated spherical nucleic acid
|
|
WO2020191361A2
(en)
|
2019-03-21 |
2020-09-24 |
Codiak Biosciences, Inc. |
Extracellular vesicles for vaccine delivery
|
|
KR20210141554A
(ko)
|
2019-03-21 |
2021-11-23 |
코디악 바이오사이언시즈, 인크. |
세포외 소포 접합체 및 이의 용도
|
|
WO2020215010A1
(en)
|
2019-04-17 |
2020-10-22 |
Codiak Biosciences, Inc. |
Compositions of exosomes and aav
|
|
WO2020242719A2
(en)
*
|
2019-05-01 |
2020-12-03 |
The University Of North Carolina At Chapel Hill |
Inhibitors of rna-binding proteins, compositions thereof, and therapeutic uses thereof
|
|
EP3976101A4
(en)
|
2019-05-31 |
2023-06-21 |
Imbria Pharmaceuticals, Inc. |
FIBROSIS TREATMENT METHODS USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION
|
|
US20220251200A1
(en)
|
2019-07-03 |
2022-08-11 |
Codiak Biosciences, Inc. |
Extracellular vesicles targeting t cells and uses thereof
|
|
WO2021011678A1
(en)
|
2019-07-15 |
2021-01-21 |
Bristol-Myers Squibb Company |
Anti-trem-1 antibodies and uses thereof
|
|
EP3999541A1
(en)
|
2019-07-15 |
2022-05-25 |
Bristol-Myers Squibb Company |
Antibodies against human trem-1 and uses thereof
|
|
CA3147365A1
(en)
|
2019-08-14 |
2021-02-18 |
Joanne LIM |
Extracellular vesicle-nlrp3 antagonist
|
|
CN120771302A
(zh)
|
2019-08-14 |
2025-10-14 |
隆萨销售股份公司 |
与分子连接的细胞外囊泡及其用途
|
|
CN114729327A
(zh)
|
2019-08-14 |
2022-07-08 |
科迪亚克生物科学公司 |
具有stat3反义寡核苷酸的细胞外囊泡
|
|
CN114729356A
(zh)
|
2019-08-14 |
2022-07-08 |
科迪亚克生物科学公司 |
靶向stat6的细胞外囊泡-aso构建体
|
|
EP4013872A1
(en)
|
2019-08-14 |
2022-06-22 |
Codiak BioSciences, Inc. |
Extracellular vesicles with antisense oligonucleotides targeting kras
|
|
EP4013878A1
(en)
|
2019-08-14 |
2022-06-22 |
Codiak BioSciences, Inc. |
Extracellular vesicle-aso constructs targeting cebp/beta
|
|
JP7331298B2
(ja)
|
2019-09-04 |
2023-08-23 |
ビオシオン インコーポレイテッド |
抗体結合ｔｓｌｐ及びその使用
|
|
JP7550769B2
(ja)
*
|
2019-09-05 |
2024-09-13 |
国立大学法人東京農工大学 |
トリプターゼ活性測定用基質
|
|
US20240377413A1
(en)
|
2019-09-16 |
2024-11-14 |
Bristol-Myers Squibb Company |
Dual capture method for analysis of antibody-drug conjugates
|
|
US12319711B2
(en)
|
2019-09-20 |
2025-06-03 |
Northwestern University |
Spherical nucleic acids with tailored and active protein coronae
|
|
US12378560B2
(en)
|
2019-10-29 |
2025-08-05 |
Northwestern University |
Sequence multiplicity within spherical nucleic acids
|
|
JP7456075B2
(ja)
|
2020-01-03 |
2024-03-27 |
ビオシオン インコーポレイテッド |
抗体結合ｂｃｍａ及びその使用
|
|
AU2021207586A1
(en)
|
2020-01-13 |
2022-07-21 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of IL-7 protein and a bispecific antibody
|
|
KR102894542B1
(ko)
|
2020-01-30 |
2025-12-03 |
(주)에임드바이오 |
벤조셀레노펜계 화합물, 이를 포함하는 약학적 조성물 및 항체-약물 결합체
|
|
CN119708230A
(zh)
|
2020-02-27 |
2025-03-28 |
正大天晴药业集团股份有限公司 |
结合il4r的抗体及其用途
|
|
EP4132971A1
(en)
|
2020-04-09 |
2023-02-15 |
Merck Sharp & Dohme LLC |
Affinity matured anti-lap antibodies and uses thereof
|
|
US12559565B2
(en)
|
2020-04-13 |
2026-02-24 |
Biosion Inc. |
Antibodies binding CTLA4 and uses thereof
|
|
US11780811B2
(en)
|
2020-06-30 |
2023-10-10 |
Imbria Pharmaceuticals, Inc. |
Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
|
|
US11530184B2
(en)
|
2020-06-30 |
2022-12-20 |
Imbria Pharmaceuticals, Inc. |
Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
|
|
CN112255908B
(zh)
*
|
2020-11-16 |
2024-12-03 |
西安轻工业钟表研究所有限公司 |
一种指针式卫星光伏时钟
|
|
CN112553274B
(zh)
*
|
2020-12-02 |
2023-06-13 |
江南大学 |
大豆提取物Bowman-Birk inhibitor切割DNA的方法
|
|
CN114685669A
(zh)
|
2020-12-30 |
2022-07-01 |
和铂医药(苏州)有限公司 |
结合trop2的抗体及其用途
|
|
EP4294456A1
(en)
|
2021-02-17 |
2023-12-27 |
Lonza Sales AG |
Extracellular vesicle linked to a biologically active molecule via an optimized linker and an anchoring moiety
|
|
EP4304640A1
(en)
|
2021-03-12 |
2024-01-17 |
Northwestern University |
Antiviral vaccines using spherical nucleic acids
|
|
JP2024510435A
(ja)
|
2021-03-18 |
2024-03-07 |
シージェン インコーポレイテッド |
生体活性化合物の内部移行複合体からの選択的薬物放出
|
|
JP2024514530A
(ja)
|
2021-04-02 |
2024-04-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
切断型ｃｄｃｐ１に対する抗体およびその使用
|
|
US11883396B2
(en)
|
2021-05-03 |
2024-01-30 |
Imbria Pharmaceuticals, Inc. |
Methods of treating kidney conditions using modified forms of trimetazidine
|
|
CA3234995A1
(en)
|
2021-10-14 |
2023-04-20 |
Latticon (Suzhou) Biopharmaceuticals Co., Ltd. |
Novel antibody-cytokine fusion protein, preparation method therefor and use thereof
|
|
CN114181216A
(zh)
*
|
2021-12-27 |
2022-03-15 |
苏州新药篮生物医药科技有限公司 |
一种3,6-二氢吡咯并[3,2-e]吲哚-2-甲酸甲酯的制备方法
|
|
AU2022446336A1
(en)
|
2022-03-18 |
2024-09-19 |
Beijing Mabworks Biotech Co., Ltd |
B7-h3-binding antibody and use thereof
|
|
AU2024305430A1
(en)
|
2023-06-12 |
2026-01-22 |
Nanjing Probio Biotech Co., Ltd. |
Antibody binding to human ccr8 and the use thereof
|
|
CN116727114B
(zh)
*
|
2023-07-19 |
2024-07-09 |
昆明理工大学 |
一种短流程浮选回收锂云母的方法
|
|
WO2025098364A1
(zh)
|
2023-11-06 |
2025-05-15 |
南京蓬勃生物科技有限公司 |
靶向人源pd-l1的全人源抗体
|
|
US20250361320A1
(en)
|
2024-02-27 |
2025-11-27 |
Bristol-Myers Squibb Company |
Anti-ceacam5 antibodies and uses thereof
|
|
TW202600596A
(zh)
*
|
2024-03-04 |
2026-01-01 |
大陸商杭州中美華東製藥有限公司 |
抗ＦＧＦＲ２ｂ抗體、其抗體藥物偶聯物及其用途
|
|
US20250282776A1
(en)
|
2024-03-05 |
2025-09-11 |
Bristol-Myers Squibb Company |
Bicyclic TLR7 Agonists and Uses Thereof
|
|
WO2025188694A1
(en)
|
2024-03-05 |
2025-09-12 |
Bristol-Myers Squibb Company |
Tricyclic tlr7 agonists and uses thereof
|